Meeting
2018 Gastrointestinal Cancers Symposium
Relationship between ethnicity and overall survival (OS) in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib (S).
Authors
Daniel E. Meyers
University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada
Daniel E. Meyers , Richard M. Lee-Ying , Mohammed Abdullah Alghamdi , Winson Y. Cheung , Haider Samawi , Vincent C. Tam
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 248)
DOI
10.1200/JCO.2018.36.4_suppl.248
Abstract #
248
Poster Bd #
C1
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
Relationship of ethnicity and overall survival (OS) in Asian patients (pts) on sorafenib for advanced hepatocellular carcinoma (HCC) in British Columbia, Canada.
First Author: Renata D'Alpino Peixoto
Poster
2020 Gastrointestinal Cancers Symposium
IGF-1 Child-Turcotte-Pugh score as a predictor of overall survival to therapy in CTP-A, BCLC stage C patients with advanced hepatocellular carcinoma.
First Author: Yehia I. Abugabal
Poster
2017 Gastrointestinal Cancers Symposium
Nivolumab dose escalation and expansion in patients with advanced hepatocellular carcinoma (HCC): The CheckMate 040 study.
First Author: Ignacio Melero
Poster
2016 Gastrointestinal Cancers Symposium
Prognostic influence of clinical biomarkers in patients (pts) with advanced hepatocellular carcinoma (HCC) receiving sorafenib: A single institution experience.
First Author: Omar Abdel-Rahman